Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | ||
Founding Date | Founding Date 2016 | Founding Date 2013 | Founding Date 2003 |
Type | Type Private | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Tucson, US HQ | Locations København, DK HQ | Locations Bundoora, AU HQ München, DE Hummelstown, US |
Employees | Employees 1220% increase | Employees 7 | Employees 20 |
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company
vivoPharm is a company that provides preclinical oncology and immuno-oncology services.
View company